Trial Profile
Genetic Variants and the Efficacy or Severe Adverse Reactions of CPT-11 Based Regimens in mCRC
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2017
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Capecitabine; Folinic acid
- Indications Colorectal cancer
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- Acronyms PSIFL
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium
- 03 Feb 2011 New trial record